1. Home
  2. CNC vs A Comparison

CNC vs A Comparison

Compare CNC & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNC
  • A
  • Stock Information
  • Founded
  • CNC 1984
  • A 1999
  • Country
  • CNC United States
  • A United States
  • Employees
  • CNC N/A
  • A N/A
  • Industry
  • CNC Medical Specialities
  • A Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CNC Health Care
  • A Industrials
  • Exchange
  • CNC Nasdaq
  • A Nasdaq
  • Market Cap
  • CNC 41.3B
  • A 41.0B
  • IPO Year
  • CNC 2001
  • A 1999
  • Fundamental
  • Price
  • CNC $76.67
  • A $138.75
  • Analyst Decision
  • CNC Buy
  • A Buy
  • Analyst Count
  • CNC 12
  • A 18
  • Target Price
  • CNC $85.58
  • A $140.56
  • AVG Volume (30 Days)
  • CNC 3.6M
  • A 1.5M
  • Earning Date
  • CNC 10-22-2024
  • A 08-21-2024
  • Dividend Yield
  • CNC N/A
  • A 0.69%
  • EPS Growth
  • CNC 9.18
  • A 25.91
  • EPS
  • CNC 5.26
  • A 4.81
  • Revenue
  • CNC $144,064,000,000.00
  • A $6,497,000,000.00
  • Revenue This Year
  • CNC N/A
  • A N/A
  • Revenue Next Year
  • CNC $3.33
  • A $4.98
  • P/E Ratio
  • CNC $14.33
  • A $28.52
  • Revenue Growth
  • CNC 4.32
  • A N/A
  • 52 Week Low
  • CNC $63.45
  • A $96.80
  • 52 Week High
  • CNC $81.42
  • A $155.35
  • Technical
  • Relative Strength Index (RSI)
  • CNC 56.84
  • A 48.81
  • Support Level
  • CNC $70.55
  • A $134.25
  • Resistance Level
  • CNC $80.59
  • A $138.86
  • Average True Range (ATR)
  • CNC 1.64
  • A 2.65
  • MACD
  • CNC -0.20
  • A -0.47
  • Stochastic Oscillator
  • CNC 64.64
  • A 39.88

About CNC Centene Corporation

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Share on Social Networks: